@GongGasGirl Interesting, this earlier trial reported benefits for sugammadex. Anecdotally I still think it's better, once available as generic I don't see why we wouldn't use it. https://t.co/569Z9VdNBm
And we have some observational evidence that Sugammadex may reduce PPCs: https://t.co/LDIkFAe4Ya https://t.co/Pu9dHulg2h. RCTs to date have been promising but not conclusive (too small ):https://t.co/1jknVrgK0H https://t.co/xQvvtNyD1K
@Der_Tscho Interessante Artikel dazu: Cost efficiency: - https://t.co/QWf83ZwppE ==>Kosten niedriger bei besserer OP Zeit - https://t.co/kT1WKSvgcG s12325-021-01701-1 ==> Kosten höher, vermutlich weniger Komplikationen Post-op complications: - http
RT @_Anesthesiology: In a multicenter matched cohort analysis, sugammadex administration was associated with a 30% reduced risk of pulmonar…
RT @ApoThera: #Sugammadex vs #Neostigmine for Reversal of Neuromuscular Blockade and Postoperative #Pulmonary Complications (STRONGER) http…
#Sugammadex vs #Neostigmine for Reversal of Neuromuscular Blockade and Postoperative #Pulmonary Complications (STRONGER) https://t.co/9wediwLb4c #anestesiologo #AnesTwitter #PulmTwitter #anesthesiology #ICU #CriticalCare #ICU #surgery #TwitteRx #Neurology
RT @_Anesthesiology: In a multicenter matched cohort analysis, sugammadex administration was associated with a 30% reduced risk of pulmonar…
RT @_Anesthesiology: In a multicenter matched cohort analysis, sugammadex administration was associated with a 30% reduced risk of pulmonar…
RT @_Anesthesiology: In a multicenter matched cohort analysis, sugammadex administration was associated with a 30% reduced risk of pulmonar…
RT @charlot_summers: This study is interesting but has issues. What is needed is a randomised trial and luckily @jon_silversides and @ruper…
RT @_Anesthesiology: In a multicenter matched cohort analysis, sugammadex administration was associated with a 30% reduced risk of pulmonar…
RT @_Anesthesiology: In a multicenter matched cohort analysis, sugammadex administration was associated with a 30% reduced risk of pulmonar…
Time to move on. We eventually stopped using halothane because we got better drugs. Neo still works ok if you use it right, but so does halothane, Pentothal, etc etc. We have a better drug now.
RT @_Anesthesiology: In a multicenter matched cohort analysis, sugammadex administration was associated with a 30% reduced risk of pulmonar…
RT @charlot_summers: This study is interesting but has issues. What is needed is a randomised trial and luckily @jon_silversides and @ruper…
RT @_Anesthesiology: In a multicenter matched cohort analysis, sugammadex administration was associated with a 30% reduced risk of pulmonar…
RT @charlot_summers: This study is interesting but has issues. What is needed is a randomised trial and luckily @jon_silversides and @ruper…
RT @charlot_summers: This study is interesting but has issues. What is needed is a randomised trial and luckily @jon_silversides and @ruper…
RT @_Anesthesiology: In a multicenter matched cohort analysis, sugammadex administration was associated with a 30% reduced risk of pulmonar…
RT @BaribeaultOFA: To every pharmacist blocking use of sugammadex "because it's too expensive" https://t.co/IaLC8bE7Ic https://t.co/MQHf7…
RT @_Anesthesiology: In a multicenter matched cohort analysis, sugammadex administration was associated with a 30% reduced risk of pulmonar…
RT @_Anesthesiology: In a multicenter matched cohort analysis, sugammadex administration was associated with a 30% reduced risk of pulmonar…
RT @_Anesthesiology: In a multicenter matched cohort analysis, sugammadex administration was associated with a 30% reduced risk of pulmonar…
RT @BaribeaultOFA: To every pharmacist blocking use of sugammadex "because it's too expensive" https://t.co/IaLC8bE7Ic https://t.co/MQHf7…
RT @BaribeaultOFA: To every pharmacist blocking use of sugammadex "because it's too expensive" https://t.co/IaLC8bE7Ic https://t.co/MQHf7…
RT @BaribeaultOFA: To every pharmacist blocking use of sugammadex "because it's too expensive" https://t.co/IaLC8bE7Ic https://t.co/MQHf7…
RT @_Anesthesiology: In a multicenter matched cohort analysis, sugammadex administration was associated with a 30% reduced risk of pulmonar…
RT @_Anesthesiology: In a multicenter matched cohort analysis, sugammadex administration was associated with a 30% reduced risk of pulmonar…
RT @_Anesthesiology: In a multicenter matched cohort analysis, sugammadex administration was associated with a 30% reduced risk of pulmonar…
RT @charlot_summers: This study is interesting but has issues. What is needed is a randomised trial and luckily @jon_silversides and @ruper…
RT @_Anesthesiology: In a multicenter matched cohort analysis, sugammadex administration was associated with a 30% reduced risk of pulmonar…
RT @charlot_summers: This study is interesting but has issues. What is needed is a randomised trial and luckily @jon_silversides and @ruper…
RT @_Anesthesiology: In a multicenter matched cohort analysis, sugammadex administration was associated with a 30% reduced risk of pulmonar…
RT @_Anesthesiology: In a multicenter matched cohort analysis, sugammadex administration was associated with a 30% reduced risk of pulmonar…
RT @BaribeaultOFA: To every pharmacist blocking use of sugammadex "because it's too expensive" https://t.co/IaLC8bE7Ic https://t.co/MQHf7…
RT @_Anesthesiology: In a multicenter matched cohort analysis, sugammadex administration was associated with a 30% reduced risk of pulmonar…
RT @charlot_summers: This study is interesting but has issues. What is needed is a randomised trial and luckily @jon_silversides and @ruper…
RT @charlot_summers: This study is interesting but has issues. What is needed is a randomised trial and luckily @jon_silversides and @ruper…
RT @nelsongiraldor: Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade and Postoperative Pulmonary Complications (STRONGE…
RT @charlot_summers: This study is interesting but has issues. What is needed is a randomised trial and luckily @jon_silversides and @ruper…
This study is interesting but has issues. What is needed is a randomised trial and luckily @jon_silversides and @rupert_pearse are on the case with SINFONIA: https://t.co/LXoVnZnXxa
RT @_Anesthesiology: In a multicenter matched cohort analysis, sugammadex administration was associated with a 30% reduced risk of pulmonar…
RT @_Anesthesiology: In a multicenter matched cohort analysis, sugammadex administration was associated with a 30% reduced risk of pulmonar…
Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade and Postoperative Pulmonary Complications (STRONGER) | Anesthesiology | American Society of Anesthesiologists https://t.co/ka1K4EaF37
RT @_Anesthesiology: In a multicenter matched cohort analysis, sugammadex administration was associated with a 30% reduced risk of pulmonar…
RT @_Anesthesiology: In a multicenter matched cohort analysis, sugammadex administration was associated with a 30% reduced risk of pulmonar…
RT @_Anesthesiology: In a multicenter matched cohort analysis, sugammadex administration was associated with a 30% reduced risk of pulmonar…
Efendimis velinimetimis
RT @NicholasChrimes: Dramatic results but > 60% of authors of this paper declare conflicts related to Merck. One is an employee of MSD!!
RT @_Anesthesiology: In a multicenter matched cohort analysis, sugammadex administration was associated with a 30% reduced risk of pulmonar…
Ça me paraît énorme comme différence personnellement. Les conditions de comparaison ne sont pas optimales quand on regarde les données (tabl 2). Bref intéressant mais pas d'énorme changement à venir selon moi.
RT @_Anesthesiology: In a multicenter matched cohort analysis, sugammadex administration was associated with a 30% reduced risk of pulmonar…
RT @_Anesthesiology: In a multicenter matched cohort analysis, sugammadex administration was associated with a 30% reduced risk of pulmonar…
RT @_Anesthesiology: In a multicenter matched cohort analysis, sugammadex administration was associated with a 30% reduced risk of pulmonar…
RT @BaribeaultOFA: To every pharmacist blocking use of sugammadex "because it's too expensive" https://t.co/IaLC8bE7Ic https://t.co/MQHf7…
RT @NicholasChrimes: Dramatic results but > 60% of authors of this paper declare conflicts related to Merck. One is an employee of MSD!!
RT @_Anesthesiology: In a multicenter matched cohort analysis, sugammadex administration was associated with a 30% reduced risk of pulmonar…
RT @_Anesthesiology: In a multicenter matched cohort analysis, sugammadex administration was associated with a 30% reduced risk of pulmonar…
RT @_Anesthesiology: In a multicenter matched cohort analysis, sugammadex administration was associated with a 30% reduced risk of pulmonar…
RT @_Anesthesiology: In a multicenter matched cohort analysis, sugammadex administration was associated with a 30% reduced risk of pulmonar…
RT @_Anesthesiology: In a multicenter matched cohort analysis, sugammadex administration was associated with a 30% reduced risk of pulmonar…
RT @_Anesthesiology: In a multicenter matched cohort analysis, sugammadex administration was associated with a 30% reduced risk of pulmonar…
RT @_Anesthesiology: In a multicenter matched cohort analysis, sugammadex administration was associated with a 30% reduced risk of pulmonar…
RT @_Anesthesiology: In a multicenter matched cohort analysis, sugammadex administration was associated with a 30% reduced risk of pulmonar…
RT @_Anesthesiology: In a multicenter matched cohort analysis, sugammadex administration was associated with a 30% reduced risk of pulmonar…
RT @_Anesthesiology: In a multicenter matched cohort analysis, sugammadex administration was associated with a 30% reduced risk of pulmonar…
Finally an anesthesia study that shows that something works
RT @DeepaKattail: Interesting results. What’s your practice: Sugammadex always or only to reverse deep paralysis (0 twitches)? #PedsAnes
Interesting results. What’s your practice: Sugammadex always or only to reverse deep paralysis (0 twitches)? #PedsAnes
RT @_Anesthesiology: In a multicenter matched cohort analysis, sugammadex administration was associated with a 30% reduced risk of pulmonar…
So sick of this, the benefits outweigh the small cost difference!
RT @_Anesthesiology: In a multicenter matched cohort analysis, sugammadex administration was associated with a 30% reduced risk of pulmonar…
RT @_Anesthesiology: In a multicenter matched cohort analysis, sugammadex administration was associated with a 30% reduced risk of pulmonar…
RT @_Anesthesiology: In a multicenter matched cohort analysis, sugammadex administration was associated with a 30% reduced risk of pulmonar…
Suggamadex para todos 🧡
RT @_Anesthesiology: In a multicenter matched cohort analysis, sugammadex administration was associated with a 30% reduced risk of pulmonar…
RT @_Anesthesiology: In a multicenter matched cohort analysis, sugammadex administration was associated with a 30% reduced risk of pulmonar…
RT @_Anesthesiology: In a multicenter matched cohort analysis, sugammadex administration was associated with a 30% reduced risk of pulmonar…
To every pharmacist blocking use of sugammadex "because it's too expensive" https://t.co/IaLC8bE7Ic https://t.co/MQHf7453KA
RT @_Anesthesiology: In a multicenter matched cohort analysis, sugammadex administration was associated with a 30% reduced risk of pulmonar…
Sugammadex 🆚 Neostygmina 🔻 55% mniejsze ryzyko niewydolności oddechowej ▫️prawie 53.000 pacjentów 🔻30% mniej powikłań oddechowych 🔻47% mniejsze ryzyko zapalenia płuc Jeśli ktoś jeszcze nie używa, powinien ponownie rozważyć za i przeciw
RT @_Anesthesiology: In a multicenter matched cohort analysis, sugammadex administration was associated with a 30% reduced risk of pulmonar…
Dramatic results but > 60% of authors of this paper declare conflicts related to Merck. One is an employee of MSD!!
RT @_Anesthesiology: In a multicenter matched cohort analysis, sugammadex administration was associated with a 30% reduced risk of pulmonar…
RT @_Anesthesiology: In a multicenter matched cohort analysis, sugammadex administration was associated with a 30% reduced risk of pulmonar…
RT @_Anesthesiology: In a multicenter matched cohort analysis, sugammadex administration was associated with a 30% reduced risk of pulmonar…
👍🏼👌🏼
RT @_Anesthesiology: In a multicenter matched cohort analysis, sugammadex administration was associated with a 30% reduced risk of pulmonar…
In a multicenter matched cohort analysis, sugammadex administration was associated with a 30% reduced risk of pulmonary complications, a 47% reduced risk of pneumonia, and a 55% reduced risk of respiratory failure compared to neostigmine. https://t.co/rGDu
@glbryson Brilliant study by @sachinkheterpal et al. HT: Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade and Postoperative Pulmonary Complications (STRONGER): A Multicenter Matched Cohort Analysis https://t.co/TOM6wvG0VW
@yusuke_mazda ありがとうございます!言葉や理屈で「リバースされてるのはいい」のは分かるんですけど、昔はアトワゴだったし、それの半減期はそんなに長くないし、と思ってたんですが、一年前に論文出てました🙄反省。
2年前の自分に、1年前の論文でマウントを取る5歳児🥺
こいつがどう思うかは問題ではない。 実際に減ったのだよ。https://t.co/3j5YGyDGIS
@GODfentanyl それはそれでまた別の話かと、、思いました! この辺りですかね。https://t.co/3j5YGyDGIS
@KArandjelovic Ooooh I see a great exam question in this! https://t.co/IVXti1eqvp
RT @_Anesthesiology: @altmetric #3: Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade and Postoperative Pulmonary Compli…
RT @_Anesthesiology: @altmetric #3: Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade and Postoperative Pulmonary Compli…
RT @_Anesthesiology: @altmetric #3: Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade and Postoperative Pulmonary Compli…
RT @_Anesthesiology: @altmetric #3: Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade and Postoperative Pulmonary Compli…